Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Read more about Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. Read more about End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Paroxysmal cold hemoglobinuria successfully treated with complement inhibition. Read more about Paroxysmal cold hemoglobinuria successfully treated with complement inhibition.
Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma. Read more about Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma.
CAR T-cell therapy: is it prime time in myeloma? Read more about CAR T-cell therapy: is it prime time in myeloma?
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Read more about Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Read more about Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1. Read more about Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.
Related and unrelated donor transplantation for β-thalassemia major: results of an international survey. Read more about Related and unrelated donor transplantation for β-thalassemia major: results of an international survey.
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Read more about Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
